

@article {3676,
	title = {Intussusception following rotavirus vaccination: an updated review of the available evidence.},
	journal = {Expert review of vaccines},
	volume = {13},
	number = {11},
	year = {2014},
	pages = {1339{\textendash}1348},
	abstract = {In 1999, the first rotavirus vaccine licensed in the \{\{\}USA\{\}\} was withdrawn 9 months after introduction due to an association with intussusception that was detected in post-licensure surveillance. This association prompted large clinical trials designed to ensure the safety of two current live oral rotavirus vaccines, \{\{\}RotaTeq\{\}\} and Rotarix, which have since been recommended for use worldwide. Following their introduction, post-licensure studies have focused not only on the effectiveness and impact of these vaccines, but also on continued surveillance for intussusception. Most recent evidence from several countries shows a small increased risk of intussusception following vaccination with Rotarix and \{\{\}RotaTeq\{\}\} within the context of their demonstrated benefits. This review summarizes the available data on the safety of rotavirus vaccines with regards to intussusception.},
	doi = {10.1586/14760584.2014.942223},
	url = {http://dx.doi.org/10.1586/14760584.2014.942223},
	author = {Rha, Brian and Tate, Jacqueline E and Weintraub, Eric and Haber, Penina and C Yen and Patel, Manish and Cortese, Margaret M and DeStefano, Frank and Parashar, Umesh D}
}
